Testing the diagnostic accuracy of a 68Ga-PSMA PET Scan in Early Biochemical Recurrence of Prostate Cancer
PET-PSMA is currently used for restaging prostate cancer (pCa) after primary surgery or radiotherapy. The PSA levels beyond which it is useful to perform it, in terms of cost-benefit ratio, are not to date clearly defined.
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2024-10-01
|
| Series: | Forum of Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/fco-2023-0034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|